Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AMX0114
AMX0114
First subject dosed in Amylyx’s Phase I trial of ALS therapy
Clinical Trials Arena
Thu, 04/10/25 - 11:49 am
Amylyx Pharmaceuticals
AMX0114
ALS
clinical trials
FDA gives Amylyx green light for phase 1 ALS trial after clinical hold
Fierce Biotech
Tue, 01/21/25 - 11:23 am
Amylyx
ALS
FDA
AMX0114
clinical trials